Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-16
Closed -$6K – 1608
2019
Q4
$6K Hold
16
– – ﹤0.01% 1379
2019
Q3
$3K Buy
+16
New +$823 ﹤0.01% 1580
2019
Q2
– Sell
-16
Closed -$1K – 1637
2019
Q1
$1K Buy
+16
New +$800 ﹤0.01% 1581
2018
Q2
– Sell
-8
Closed -$1K – 1584
2018
Q1
$1K Buy
+8
New +$373 ﹤0.01% 1556

Other funds holding GSK

M&T Bank's GSK Position: Q2 2026 in Review

M&T Bank increased its GSK (GSK) stake by 4.5% in Q2 2026, buying an estimated $98K and bringing the position to 42,652 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #613.

M&T Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $34M in Q3 2017. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • M&T Bank held 42,652 shares of GSK worth $2.24M as of Q2 2026.
  • M&T Bank bought 1,853 GSK shares in Q2 2026, an estimated $98K.
  • GSK made up 0.01% of M&T Bank's portfolio in Q2 2026, its #613 holding.
  • M&T Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • M&T Bank's GSK position peaked at $34M in Q3 2017.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.